NM
Newtyn Management Portfolio holdings
AUM
$660M
This Quarter Return
-0.44%
1 Year Return
+22.08%
3 Year Return
+41.34%
5 Year Return
+148.8%
10 Year Return
+127.87%
AUM
$509M
AUM Growth
+$509M
(+5%)
Cap. Flow
-$1.42M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
47.79%
Holding
85
New
14
Increased
21
Reduced
36
Closed
5
Top Buys
| 1 |
G-III Apparel Group
GIII
|
$23.9M |
| 2 |
Customers Bancorp
CUBI
|
$8.8M |
| 3 |
Q2 Holdings
QTWO
|
$7.39M |
| 4 |
TSVT
2seventy bio
TSVT
|
$6.35M |
| 5 |
Star Holdings Shares of Beneficial Interest
STHO
|
$5.64M |
Top Sells
| 1 |
SAFE
Safehold
SAFE
|
$37.5M |
| 2 |
AVTA
Avantax, Inc. Common Stock
AVTA
|
$23.7M |
| 3 |
1-800-Flowers.com
FLWS
|
$7.39M |
| 4 |
IVAC
Intevac Inc
IVAC
|
$3.36M |
| 5 |
ONL
Orion Office REIT
ONL
|
$2.93M |
Sector Composition
| 1 | Consumer Discretionary | 23.36% |
| 2 | Healthcare | 20.73% |
| 3 | Financials | 12.06% |
| 4 | Communication Services | 9.18% |
| 5 | Real Estate | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Bolt Biotherapeutics
BOLT
$9.85M
| $1.55M | 0.3% |
1,115,110
-34,890
| -3% | -$48.5K |
|
|
TCRR
52
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $1.52M | 0.3% |
1,015,920
-59,080
| -5% | -$88.6K |
|
53
Olema Pharmaceuticals
OLMA
$375M
| $1.3M | 0.26% |
375,000
+15,000
| +4% | +$52.1K |
|
54
Adverum Biotechnologies
ADVM
$64.6M
| $1.1M | 0.22% |
1,528,400
-106,600
| -7% | -$76.5K |
|
|
ORKA
55
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
| $1.03M | 0.2% |
519,765
-18,513
| -3% | -$36.8K |
|
56
Alpha Metallurgical Resources
AMR
$1.95B
| $986K | 0.19% |
6,319
| – | – |
|
57
Alector
ALEC
$238M
| $959K | 0.19% |
155,000
+10,000
| +7% | +$61.9K |
|
|
LTCH
58
DELISTED
Latch, Inc. Common Stock
LTCH
| $915K | 0.18% |
1,200,000
-290,000
| -19% | -$221K |
|
59
Aligos Therapeutics
ALGS
$73.3M
| $893K | 0.18% |
1,021,461
-478,539
| -32% | -$418K |
|
60
First Foundation Inc
FFWM
$490M
| $782K | 0.15% |
+105,000
| New | +$782K |
|
|
DBTX
61
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $767K | 0.15% |
253,818
-16,182
| -6% | -$48.9K |
|
62
Oric Pharmaceuticals
ORIC
$994M
| $764K | 0.15% |
133,999
-11,001
| -8% | -$62.7K |
|
63
CytomX Therapeutics
CTMX
$336M
| $642K | 0.13% |
425,000
-145,000
| -25% | -$219K |
|
64
Iovance Biotherapeutics
IOVA
$807M
| $642K | 0.13% |
105,000
-15,000
| -13% | -$91.7K |
|
65
Passage Bio
PASG
$22.7M
| $637K | 0.13% |
665,221
-124,779
| -16% | -$120K |
|
66
GeneDx Holdings
WGS
$3.72B
| $622K | 0.12% |
1,705,000
-295,000
| -15% | -$108K |
|
67
Black Diamond Therapeutics
BDTX
$157M
| $579K | 0.11% |
306,609
-8,391
| -3% | -$15.9K |
|
68
Ponce Financial Group
PDLB
$338M
| $552K | 0.11% |
+70,351
| New | +$552K |
|
69
TScan Therapeutics
TCRX
$102M
| $497K | 0.1% |
236,800
+6,800
| +3% | +$14.3K |
|
70
Forte Biosciences
FBRX
$137M
| $415K | 0.08% |
410,740
-138,008
| -25% | -$139K |
|
71
Comp X International
CIX
$306M
| $375K | 0.07% |
20,737
-34,738
| -63% | -$628K |
|
72
Columbia Financial
CLBK
$1.58B
| $358K | 0.07% |
+19,600
| New | +$358K |
|
73
Nuvation Bio
NUVB
$1.02B
| $357K | 0.07% |
215,000
-25,000
| -10% | -$41.5K |
|
74
IO Biotech
IOBT
$104M
| $92.3K | 0.02% |
49,346
-40,654
| -45% | -$76K |
|
|
BRLIR
75
DELISTED
Brilliant Acquisition Corporation Rights
BRLIR
| $65.9K | 0.01% |
457,409
| – | – |
|